In a surprising pivot, Coeptis Therapeutics, a publicly traded biopharmaceutical company, has announced a dramatic shift in its business strategy. After years of developing therapies for cancer, infectious diseases, and autoimmune conditions, the company is spinning off its life sciences division to focus on an entirely different venture: Dogecoin mining.